87.97
0.16 (0.18%)
| Previous Close | 87.81 |
| Volume | 199,810 |
| Price / Earnings (Forward) | 18.78 |
| Price / Sales | 3.28 |
| Price / Book | 3.01 |
| 52 Weeks Range |
| Profit Margin | 8.81% |
| Operating Margin (TTM) | 11.83% |
| Diluted EPS (TTM) | 2.04 |
| Quarterly Revenue Growth (YOY) | 9.80% |
| Quarterly Earnings Growth (YOY) | 6.80% |
| Total Debt/Equity (MRQ) | 57.24% |
| Current Ratio (MRQ) | 4.87 |
| Operating Cash Flow (TTM) | 225.16 M |
| Levered Free Cash Flow (TTM) | 172.75 M |
| Return on Assets (TTM) | 4.32% |
| Return on Equity (TTM) | 9.16% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | Merit Medical Systems, Inc. | Mixed | Bullish |
Similar Stocks
| Stock | Market Cap | DY | P/E (TTM) | P/B |
|---|---|---|---|---|
| MMSI | - | - | - | 3.01 |
| SMTI | - | - | - | 36.64 |
| MBOT | - | - | - | 1.03 |
| AZTA | - | - | - | 1.18 |
| PLSE | - | - | - | 22.01 |
| LMAT | - | 1.21% | - | 4.29 |
AIStockmoo Score
| Value 35% | 3.6 |
| AI Insight info | NA |
| Relative Valuation info | 4.3 |
| Financial Health info | 2.6 |
| Timing 35% | -0.3 |
| AI Technical info | NA |
| Technical Oscillators info | -0.5 |
| Technical Moving Averages info | 0.0 |
| Smart Money 30% | 0.0 |
| Analyst Consensus info | 0.0 |
| Insider Activity info | NA |
| News Mood info | NA |
| Environment | ×0.89 |
| Macro Environment info | -3.3 |
| Sector vs Market (6M) | +4.4% |
| Pillar Agreement | ×1.00 |
| Not in score | |
| Price Volatility info | -0.3 |
| Final Score | 1.04 |
Select this tab to load the latest available analysis.
|
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Growth |
| % Held by Insiders | 2.23% |
| % Held by Institutions | 109.41% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Conestoga Capital Advisors, Llc | 30 Sep 2026 | 1,510,239 |
| Greenhouse Funds Lllp | 30 Jun 2026 | 1,072,098 |
No data within this time range.
No data within this time range.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |